889
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

Long non-coding RNA HCG18 promotes gastric cancer progression by regulating miRNA-146a-5p/tumor necrosis factor receptor-associated factor 6 axis

&
Pages 6781-6793 | Received 29 Sep 2021, Accepted 21 Jan 2022, Published online: 04 Mar 2022

References

  • Wagner DA, Grothe W, Haerting J. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol Off J Am Soc Clin Oncol. 2006;24(18):2903.
  • Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357(18):1810–1820.
  • None. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20(1):1–19.
  • Murad AM, Santiago FF, Petroianu A, et al. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer. 2015;72(1):37–41.
  • Js M. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine - NEJM. Cancer Lett. 2007;357:1810–1820.
  • Baek SH, Cho JY, Song HJ, et al. Characteristics of metachronous multiple early gastric cancers after endoscopic mucosal resection. Gastrointest Endosc. 2005;63:990–993.
  • Mizuno T, Mizushima S. Signal transduction and gene regulation through the phosphorylation of two regulatory components: the molecular basis for the osmotic regulation of the porin genes. Mol Microbiol. 2010;4(7):1077–1082.
  • Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 2009;458(7235):223.
  • Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012;22(9):1775–1789.
  • Pestell RG, Yu Z. Long and noncoding RNAs (lnc-RNAs) determine androgen receptor dependent gene expression in prostate cancer growth in vivo. Asian J Androl. 2014;16(2):268–269.
  • Xu M, He Z, Ling L, et al. Expression profiles analysis of long non-coding RNAs identified novel lncRNA biomarkers with predictive value in outcome of cutaneous melanoma. Oncotarget. 2017;8(44):77761–77770.
  • Liu S, Mitra R, Zhao MM, et al. The potential roles of long noncoding RNAs (lncRNA) in glioblastoma development. Mol Cancer Ther. 2016;15(12):2977.
  • Jiménez B, Tiana M, Del PL. lnc RNAs, hypoxia and metastasis. Oncoscience. 2015;2(10):795–796.
  • Tianwei XU, and Wang Z. Research progress in lnc RNAs and the diagnosis, prognosis, and drug resistance of gastric cancer. Chinese Journal of Clinical Oncology. 2015;42:71–76.
  • Yang G, Lu X, Yuan L. LncRNA: a link between RNA and cancer. Biochim Biophys Acta. 2014;1839(11):1097–1109.
  • Xiang JF, Yin Q-F, Chen T, et al. Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus. Cell Res. 2014;24(5):513–531.
  • Zhihui X, Banggao H, and Zhang Q, et al. NOTCH1 regulates the proliferation and migration of bladder cancer cells by cooperating with long non-coding RNA HCG18 and microRNA-34c-5p. J Cell Biochem. 2018;120(4): 6596–6604.
  • Wang W, Zhao Z, Yang F, et al. An immune-related lncRNA signature for patients with anaplastic gliomas. J Neurooncol. 2018;136(2):263–271.
  • Chen X. Predicting lncRNA-disease associations and constructing lncRNA functional similarity network based on the information of miRNA. Sci Rep. 2015;5:13186.
  • Smirnova L, Grafe A, Seiler A, et al. Regulation of miRNA expression during neural cell specification. Eur J Neurosci. 2015;21(6):1469–1477.
  • Laurent LC, Chen J, Ulitsky I, et al. Comprehensive MicroRNA profiling reveals a unique human embryonic stem cell signature dominated by a single seed sequence. Stem Cells. 2010;26(6):1506–1516.
  • Li X, Zhang Y, Zhang H, et al. miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res. 2011;9(7):824–833.
  • Chang HK, Kim HK, and Rettig RL, et al. miRNA signature associated with outcome of gastric cancer patients following chemotherapy. BMC Med Genomics. 2011;4: 79. :
  • Li H, Xie S, Liu M, et al. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis. Int J Oncol. 2014;45(1):197.
  • Li JP, Zhang HM, Liu MJ, et al. miR-133a-3p/FOXP3 axis regulates cell proliferation and autophagy in gastric cancer. J Cell Biochem. 2020;121(5–6):3392–3405.
  • Zhang HM, Li H, Wang GX, et al. MKL1/miR-5100/CAAP1 loop regulates autophagy and apoptosis in gastric cancer cells. Neoplasia. 2020;22(5):220–230.
  • Kogo R, Mimori K, Tanaka F, et al. Clinical significance of miR-146a in gastric cancer cases. Clin Cancer Res. 2011;17(13):4277–4284.
  • Yamashita M, Fatyol K, Jin C, et al. TRAF6 mediates smad-independent activation of JNK and p38 by TGF-β. Mol Cell. 2008;31(6):918–924.
  • Liang W-C, Fu W-M, Wong C-W, et al. The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. Oncotarget. 2015;6:22513–22525.
  • Kadono Y, Okada F, Perchonock C, et al. Strength of TRAF6 signalling determines osteoclastogenesis. EMBO Rep. 2005;6(2):171.
  • Sun YS, Ye ZY, Qian ZY, et al. Expression of TRAF6 and ubiquitin mRNA in skeletal muscle of gastric cancer patients. J Exp Clin Cancer Res. 2012;31(1): 81-. doi:10.1186/1756-9966-31-81.
  • Zhu M, Wang M, Yang F, et al. miR-155-5p inhibition promotes the transition of bone marrow mesenchymal stem cells to gastric cancer tissue derived MSC-like cells via NF-κB p65 activation. Oncotarget. 2016;7(13):16567–16580.
  • Clement T, Salone V, Rederstorff M. Dual luciferase gene reporter assays to study miRNA function. Methods Mol Biol. 2015;1296:187–198.
  • Guenin S, Mauriat M, Pelloux J, et al. Normalization of qRT-PCR data: the necessity of adopting a systematic, experimental conditions-specific, validation of references. J Exp Bot. 2009;60(2):487–493.
  • Wei CH, Wu G, Cai Q, et al. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway. J Hematol Oncol. 2017;10:125.
  • Meng F, Li Z, Zhang Z, et al. MicroRNA-193b-3p regulates chondrogenesis and chondrocyte metabolism by targeting HDAC3. Theranostics. 2018;8(10):2862–2883.
  • Menzel HJ, Utermann G. Apolipoprotein E phenotyping from serum by Western blotting. Electrophoresis. 2010;7(11):492–495.
  • Hartgrink HH, Jansen EPM, Grieken NCTV, et al. Gastric cancer. Lancet. 2009;374:477–490.
  • Di J, Ji H, Ji F, et al. Current status and development trends of morbidity and mortality in gastric cancer patients in Xining, 2009-2016. Am J Transl Res. 2021;13:12431–12439.
  • Chon SH, Berlth F, Plum PS, et al. Gastric cancer treatment in the world: Germany. Transl Gastroenterol Hepatol. 2017;2(5):53.
  • Finke J, Engelhardt R. Chemotherapy for advanced gastric cancer. Dig Surg. 2010;11(2):118–120.
  • Fujimoto-Ouchi K, Sekiguchi F, Yasuno H, et al. Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models. Cancer Chemotherapy & Pharmacology. 2007;59(6):795–805.
  • Shao Y, and Ji D, Oncology DO. The newest research progress of gastric cancer molecular targeted therapy. Journal of Modern Oncology. 2015;13:1778–1782.
  • Kameswaran V, Kaestner KH. The missing lnc(RNA) between the pancreatic β-cell and diabetes. Front Genet. 2014;5: 200-. doi:10.3389/fgene.2014.00200.
  • Lin Z, Zhou Z, Guo H, et al. Long noncoding RNA gastric cancer-related lncRNA1 mediates gastric malignancy through miRNA-885-3p and cyclin-dependent kinase 4. Cell Death Dis. 2018;9(6):607.
  • Wang CY, Hua L, Yao KH, et al. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis. Int J Clin Exp Pathol. 2015;8:779–785.
  • Zhang Y, Ma M, Liu W, et al. Enhanced expression of long noncoding RNA CARLo-5 is associated with the development of gastric cancer. Int J Clin Exp Pathol. 2014;7:8471–8479.
  • Yang Z, OuYang X, Zheng L, et al. Long intergenic noncoding RNA00265 promotes proliferation of gastric cancer via the microRNA-144-3p/Chromobox 4 axis. Bioengineered. 2021;12(1):1012–1025.
  • Chen X, and Liu P, Pathophysiology DO. Expression of Lnc RNA HCG11 and mi R-590-3p in squamous carcinoma of cervix and their relationship with prognosis. Cancer Research on Prevention & Treatment. 2018;45(3): 148–153.
  • Wan X, Ding X, Chen S, et al. The functional sites of miRNAs and lncRNAs in gastric carcinogenesis. Tumor Biol. 2015;36(2):521–532.
  • Liu X-H, Sun M, Nie F-Q, et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer. 2014;13(1):92.
  • Qi P, Xu M-D, Shen X-H, et al. Reciprocal repression between TUSC7 and miR-23b in gastric cancer. Int J Cancer J Inter du Cancer. 2015;137(6):1269–1278.
  • Lin SL, Chiang A, Chang D, et al. Loss of mir-146a function in hormone-refractory prostate cancer. RNA. 2008;14(3):417–424.
  • Xi Y, Jiang T, Wang W, et al. Long non-coding HCG18 promotes intervertebral disc degeneration by sponging miR-146a-5p and regulating TRAF6 expression. Sci Rep. 2017;7(1):13234.
  • Wu Q, Han L, Yan W, et al. miR-489 inhibits silica-induced pulmonary fibrosis by targeting MyD88 and Smad3 and is negatively regulated by lncRNA CHRF. Sci Rep. 2016;6(1):30921.
  • Hauer J, Puschner S, Ramakrishnan P, et al. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-?B pathway by TRAF-binding TNFRs. Proc Natl Acad Sci U S A. 2005;102(8):2874–2879.
  • Sundar R, Landström M. TRAF6. 2016.
  • Zhou F, Wei H, Ding A, et al. Different cellular localization of NF-κB p65 expression as an indicator of different prognoses of stage I-III gastric cancer patients. Clin Transl Sci. 2013;6(5):381–385.